Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Percutaneous navigation-assisted versus open posterior fixation for thoracolumbar fractures in ankylosing spinal diseases: a single-institution 15-year cohort analysis.

Journal of neurosurgery. Spine·2026
Same author

Identification of the promoter region of the human P2RX7 gene.

Purinergic signalling·2026
Same author

Radiographic predictors of lumbar disc re-herniation requiring repeat discectomy or fusion: a matched retrospective cohort analysis.

The spine journal : official journal of the North American Spine Society·2026
Same author

Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance.

Neurochemistry international·2025
Same author

Full Endoscopic Peripheral Nerve Sheath Tumor Resection With Triportal Bimanual Maneuver: 2-Dimensional Operative Video.

Operative neurosurgery (Hagerstown, Md.)·2025
Same author

Thoracic stenosis decompression using Bi-portal endoscopic technique.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2025
Same journal

Breaking barriers: Enhancing access to dementia clinical trials in the United Kingdom-Insights from the Scientific Advisory Board of the Dame Barbara Windsor Dementia Goals Programme.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Estimated labor market outcomes of people progressing from preclinical to early-stage Alzheimer's disease in the United States.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Amyloid exacerbates tau and alpha-synuclein pathologies, behavioral impairments, and neuroinflammation in a mixed dementia model.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Xin Huang1,2,3, Jennica Wang1, Yoshiteru Kagawa1,2

  • 1The University of Melbourne, Parkville, VIC, Australia.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括
此摘要是机器生成的。

在免疫细胞中,ApoE3和ApoE4的Apolipoprotein E (ApoE) 异型抑制了细胞化. 虽然两者都减少了粉样β (Aβ) 的摄取,但ApoE4的Aβ结合较少,可能会启动阿尔茨海默氏症 (AD) 病原发生.

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 遗传学 是一个遗传学.

背景情况:

  • APOE ε4等位基因是阿尔茨海默病 (AD) 的主要遗传风险因素,与早期发病有关.
  • ApoE4与阿米洛伊德β (Aβ) 聚合和早期AD病变的脂质滴形成有关.
  • 阿波E在Aβ细胞分裂中的作用及其基于异型的差异效应仍然不清楚.

研究的目的:

  • 研究Apolipoprotein E3 (ApoE3) 和Apolipoprotein E4 (ApoE4) 对免疫细胞Aβ细胞的影响.
  • 为了确定ApoE异型是否对Aβ清除机制产生差异影响.
  • 探索ApoE,脂质滴滴形成和细胞活动之间的关系.

主要方法:

  • 使用表达ApoE3或ApoE4的HEK293细胞来分离蛋白质.
  • 使用THP-1单细胞和光珠进行实时流细胞计,以评估细胞.
  • 使用BV2微质与pHrodo-red Aβ寡合体和LipidSpot染色来评估Aβ内细胞和脂滴形成.

主要成果:

  • 根据剂量,ApoE3和ApoE4都抑制了单细胞对珠的细胞化.
  • ApoE异型减少了微质中的Aβ寡合体内和酸化.
  • 与ApoE3相比,ApoE4显示Aβ寡合体的结合减少,而这两种异构体都减少了脂质滴滴的形成.

结论:

  • ApoE异构体抑制单细胞和微质细胞中的细胞活性,无论具体的异构体是什么.
  • 由ApoE4减少的Aβ表面结合表明Aβ辅导功能受损,可能导致AD的初始Aβ聚合.
  • 这些发现揭示了ApoE在阿尔茨海默氏症病原发生中的异型特异性机制.